Drug Profile

TAVT 135

Alternative Names: TAVT-135

Latest Information Update: 28 Oct 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Tavanta Therapeutics
Class Antifibrotics; Drug conjugates; Peptides; Small molecules
Mechanism of Action Chloride channel agonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes
Available For Licensing Yes

Highest Development Phases

No development reported Cystic fibrosis

Most Recent Events

28 Oct 2024 No recent reports of development identified for preclinical development in Cystic-fibrosis in USA (Inhalation)
24 May 2023 Pharmacodynamics data from a preclinical trial in Cystic fibrosis released by Tavanta Therapeutics
19 May 2023 Preclinical pharmacodynamics data from an in vitro study in Cystic fibrosis presented at the 119^th International Conference of the American Thoracic Society (ATS-2023)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com